Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1991;83:224-236

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miller, D. D.
Right arrow Articles by Berger, H. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miller, D. D.
Right arrow Articles by Berger, H. J.

Circulation, Vol 83, 224-236, Copyright © 1991 by American Heart Association


ARTICLES

In vivo technetium-99m S12 antibody imaging of platelet alpha-granules in rabbit endothelial neointimal proliferation after angioplasty

DD Miller, AJ Boulet, FO Tio, OJ Garcia, DM Guy, RP McEver, JC Palmaz, KY Pak, DS Neblock and HJ Berger
Department of Medicine, University of Texas Health Science Center, San Antonio 78284-7872.

To examine the specificity of technetium-99m monoclonal antibody (S12) imaging for identifying activated platelets at interventional injury sites in atherosclerotic rabbit arteries, subgroups of unheparinized rabbits (n = 39) underwent serial percutaneous transluminal aortic angioplasty (PTA) procedures (with or without intravascular stent placement) followed by in vivo and then ex vivo gamma camera imaging, scanning, and immunoelectron microscopy to determine the intravascular loci of S12 Fab' antibody binding. Despite angiographic vessel patency, image-derived ratios of in vivo S12 binding in injured versus uninjured vascular segments were significantly increased (p less than 0.05) after one PTA (1.3 +/- 0.17, n = 7), PTA twice at 6-week intervals (1.4 +/- 0.22, n = 7), and PTA plus stent placement (1.6 +/- 0.28, n = 7) compared with control experiments (1.1 +/- 0.13, n = 7). Ex vivo imaging of blood-free excised aortas confirmed S12 localization at PTA (2 +/- 0.4, n = 3) and PTA plus stent placement (5 +/- 3.8, n = 7) sites (both p less than 0.05 versus controls). S12 antibody uptake decreased significantly (p less than 0.05) at 1 week after PTA plus stent placement in vivo (1.1 +/- 0.10, n = 4) and ex vivo (1.6 +/- 0.7, n = 3). Electron microscopic studies confirmed dense platelet, fibrin, and red blood cell deposition in regions of acute injury, with endothelial neointimal proliferation at 1 week after PTA. Immunoelectron microscopic studies confirmed specific in vivo S12 binding (22:1 versus nonrelevant IgG) at sites of alpha-granule GMP-140 expression in activated platelets. Therefore, S12 studies may be useful to localize sites of platelet-derived mitogen release at arterial PTA injury sites.


This article has been cited by other articles:


Home page
CirculationHome page
J. R. Stratton, T. A. Dewhurst, S. Kasina, J. M. Reno, M. D. Cerqueira, D. G. Baskin, and J. F. Tait
Selective Uptake of Radiolabeled Annexin V on Acute Porcine Left Atrial Thrombi
Circulation, November 15, 1995; 92(10): 3113 - 3121.
[Abstract] [Full Text]


Home page
CirculationHome page
J. Narula, A. Petrov, C. Bianchi, C. C. Ditlow, B. C. Lister, J. Dilley, I. Pieslak, F. W. Chen, V. P. Torchilin, and B.-A. Khaw
Noninvasive Localization of Experimental Atherosclerotic Lesions With Mouse/Human Chimeric Z2D3 F(ab')2 Specific for the Proliferating Smooth Muscle Cells of Human Atheroma : Imaging With Conventional and Negative Charge–Modified Antibody Fragments
Circulation, August 1, 1995; 92(3): 474 - 484.
[Abstract] [Full Text]